Nicolas Pietrancosta

Dr. Nicolas Pietrancosta

Lab of Biomolecules, Sorbonne Universite, Paris, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NPNicolas Pietrancosta
Nicolas Pietrancosta
AMAnice Moumen
Anice Moumen
RDRosanna Dono
Rosanna Dono
Paul LingorPaul Lingor
Paul Lingor
VPVeronique Planchamp
Veronique Planchamp
FMFlavio Maina
Flavio Maina

29 August 2012 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
YLYounes Laras
Younes Laras
VHVincent Hugues
Vincent Hugues
YCYogesh Chandrasekaran
Yogesh Chandrasekaran
MBMireille Blanchard-Desce
Mireille Blanchard-Desce
FAFrancine C. Acher
Francine C. Acher
NPNicolas Pietrancosta
Nicolas Pietrancosta

30 May 2020 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NPNicolas Pietrancosta
Nicolas Pietrancosta
MDMahamadou Djibo
Mahamadou Djibo
SDStephanie Daumas
Stephanie Daumas
SMSalah El Mestikawy
Salah El Mestikawy
JEJeffrey D. Erickson
Jeffrey D. Erickson

1 January 2005 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
CGCédrik Garino
Cédrik Garino
FBFrédéric Bihel
Frédéric Bihel
NPNicolas Pietrancosta
Nicolas Pietrancosta
YLYounes Laras
Younes Laras
GQGilles Quéléver
Gilles Quéléver
JKJean-Louis Kraus
Jean-Louis Kraus

9 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CMCécile Morlot
Cécile Morlot
DSDaniel Straume
Daniel Straume
KPKatharina Peters
Katharina Peters
OHOlav A. Hegnar
Olav A. Hegnar
NSNolwenn Simon
Nolwenn Simon
AZAndré Zapun
André Zapun
The universality of peptidoglycan in bacteria underlies the broad spectrum of many successful antibiotics. However, in our times of widespread resistance, the diversity of peptidoglycan modifications offers a variety of new antibacterials targets. In some Gram-positive species such as Streptococcus pneumoniae, Staphylococcus aureus, or Mycobacterium tuberculosis, the second residue of the peptidoglycan precursor, D-glutamate, is amidated into iso-D-glutamine by the essential amidotransferase MurT/GatD complex. Here, we present the structure of this complex at 3.0 Å resolution. MurT has central and C-terminal domains similar to Mur ligases with a cysteine-rich insertion, which probably binds zinc, contributing to the interface with GatD. The mechanism of amidation by MurT is likely similar to the condensation catalyzed by Mur ligases. GatD is a glutaminase providing ammonia that is likely channeled to the MurT active site through a cavity network. The structure and assay presented here constitute a knowledge base for future drug development studies.

10 June 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CGCédrik Garino
Cédrik Garino
Taisuke TomitaTaisuke Tomita
Taisuke Tomita
NPNicolas Pietrancosta
Nicolas Pietrancosta
YLYounes Laras
Younes Laras
RRRoselyne Rosas
Roselyne Rosas
JKJean-Louis Kraus
Jean-Louis Kraus